Wilson Sonsini Goodrich & Rosati advised Autobahn Therapeutics on the transaction. Autobahn Therapeutics, a biotechnology company, announced the closing of an oversubscribed $100 million Series C...
Wilson Sonsini Goodrich & Rosati advised Autobahn Therapeutics on the transaction. Autobahn Therapeutics, a biotechnology company, announced the closing of an oversubscribed $100 million Series C...
You must be a Standard 1 Year member to access this content.